Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Chengdu Maxvax Biotechnology

Explore full profile

CDMO for plasmid DNA, mRNA, and proteins.

Chengdu, ChinaFounded 2016Biotech & Life Sciences
Valuation $1–2.5B Last recorded · 2026
Revenue $1–10M Latest reported FY
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Chengdu Maxvax Biotechnology and the history behind them.

At a glance

Founded
2016
Headquarters
Chengdu, China
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

Series B and later11 investors entered at this stage

  • Fangshizhen Capital
  • IDG Capital
  • Qianhai FOF
  • Xinshang Capital
  • GF Qianhe
  • Guohai Innovative CCI Capital
  • Sherpa Investment
  • Gortune Investment
  • China Life Private Equity Investment
  • Shenzhen Capital Group
  • Shanghai Hankang Private Equity Fund Management

Ownership

Share of equity by holder

Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.

34.7% Founders

Some investors are hidden on this public profile. “Other / undisclosed” is the 4.8% not attributed to a named shareholder. See the full cap table on Dealroom →

Talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Chengdu HQ
Book a demo for the full country breakdown
Web traffic by country
130 monthly visits
across markets
🇺🇸 United States76.9%
Top 1 markets shown

Patents

Estimated portfolio value
$3M

143 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Chengdu Maxvax Biotechnology on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Chengdu Maxvax Biotechnology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles